Prostate cancer is the most commonly diagnosed cancer in the UK. But screening is not universal, and charities are divided over whether it should be extended. What do those living with the disease ...

The analysis – reported at the European Association of Urology (EAU) annual congress in London, UK – shows that it is "no ...

Early-stage prostate cancer rarely causes symptoms, making routine screening the most reliable way to catch it before it ...

Prostate cancer is one of the leading causes of cancer-related death in men, and some experts project the number of cases to ...

The CAPTAIN trial shows faster recovery, fewer complications, and better early function with the minimally invasive therapy ...

Results challenge view that high testosterone fuels prostate cancer growth ...

As a result, researchers have explored less invasive options that aim to treat the cancer while preserving quality of life. One such approach is TULSA, which uses real-time MRI guidance to deliver ...

Detailed price information for Profound Medical Corp (PROF-Q) from The Globe and Mail including charting and trades.

Discusses First Clinical Outcomes and Precision of TULSA from the CAPTAIN Trial in Prostate Cancer March 13, 2026 11:30 ...

Prostate-specific membrane androgen PET/CT can help clinicians intensify or de-escalate care for men with prostate cancer who ...

First multicenter, randomized controlled trial directly comparing a new technology to robotic RP for men with localized prostate cancer to successfully recruit to target enrollment – – TULSA treatment ...

After a routine blood test led to his diagnosis, the 70-year-old travel expert urges everyone to prioritize health exams.